NYSE:SYK
Stryker Corp. (SYK)
Financials 
Technical Analysis 
Aug 15, 2026, 12:00 amThis summary was created by AI, based on 8 opinions in the last 12 months.
Stryker Corp. (SYK) remains a leading player in the medical device sector, particularly in orthopedics, holding a significant market share in the U.S. With its robust robotics platform and the increasing demand driven by aging demographics, particularly in hip and knee replacements, the company shows strong potential for recovery from recent challenges, including a cybersecurity attack. Despite recent weaknesses in the broader medtech industry, many analysts express optimism around SYK's growth trajectory, with expectations of revenue and earnings per share advancing in the coming years. Additionally, Stryker's solid relationships with healthcare providers and a sticky business model (where surgeons tend to stick with suppliers) position it well for sustained success. However, some experts caution that while the stock may have long-term merits, the current investment climate may not be optimal.
Medical devices. Has grown through acquisition. Long track record of dividend growth and have grown 25% over the last 5 years. Trading at around 16X earnings.
John O'Connell, CFA
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20scale(-1,%201)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Sees opportunities in developing markets and demographics play a good role. Feels their abilities and for similar companies in the medical device area, is to participate with the goal of lowering costs. Companies like this that make the devices, have the opportunity to help lower costs, which will be better for consumers and governments and will ultimately provide better care. Long-term theme.